Holen Sie sich die Stockscreener-App
312.14
1.60%
4.91
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$307.23
Offen:
$304.46
24-Stunden-Volumen:
1.26M
Relative Volume:
1.43
Marktkapitalisierung:
$30.62B
Einnahmen:
$3.17B
Nettoeinkommen (Verlust:
$642.63M
KGV:
29.00
EPS:
10.765
Netto-Cashflow:
$516.49M
1W Leistung:
-4.34%
1M Leistung:
-17.63%
6M Leistung:
+7.61%
1J Leistung:
-16.04%
1-Tages-Spanne:
$300.95
$313.08
1-Wochen-Bereich:
$300.95
$327.28
52-Wochen-Spanne:
$275.05
$414.15
Waters Corp Stock (WAT) Company Profile
Firmenname
Waters Corp
Sektor
Branche
Telefon
(508) 478-2000
Adresse
34 MAPLE ST, MILFORD, MA
Compare WAT vs TMO, DHR, IDXX, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
312.14 | 30.14B | 3.17B | 642.63M | 516.49M | 10.77 |
|
TMO
Thermo Fisher Scientific Inc
|
508.10 | 191.08B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
204.01 | 145.67B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
635.54 | 50.70B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
119.04 | 33.42B | 6.95B | 1.30B | 1.15B | 4.5696 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-10 | Fortgesetzt | Barclays | Overweight |
| 2026-02-10 | Fortgesetzt | Citigroup | Buy |
| 2026-02-10 | Fortgesetzt | Evercore ISI | In-line |
| 2026-01-06 | Eingeleitet | Guggenheim | Buy |
| 2026-01-05 | Eingeleitet | William Blair | Outperform |
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-10-08 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-03-31 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-26 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-01 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2023-11-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-05-18 | Eingeleitet | Barclays | Overweight |
| 2022-05-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-04-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-01-07 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-17 | Hochstufung | Cleveland Research | Underperform → Buy |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-07-28 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-07-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-01-08 | Herabstufung | Needham | Hold → Underperform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Sell |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-09 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2019-07-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-06-12 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-01-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-03 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-01-03 | Eingeleitet | Needham | Hold |
| 2018-12-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-30 | Herabstufung | Goldman | Neutral → Sell |
| 2018-10-11 | Hochstufung | Cleveland Research | Sell → Neutral |
Alle ansehen
Waters Corp Aktie (WAT) Neueste Nachrichten
Down 19% in 4 Weeks, Here's Why You Should You Buy the Dip in Waters (WAT) - Finviz
Waters Corp. stock underperforms Monday when compared to competitors - MarketWatch
Citigroup Inc. Sells 24,449 Shares of Waters Corporation $WAT - MarketBeat
WAT PE Ratio & Valuation, Is WAT Overvalued - Intellectia AI
Erste Asset Management GmbH Grows Stock Holdings in Waters Corporation $WAT - MarketBeat
Aviso Financial Inc. Raises Stock Position in Waters Corporation $WAT - MarketBeat
Waters (WAT) director granted stock options and restricted shares - Stock Titan
Waters (NYSE: WAT) director awarded stock option and restricted shares - Stock Titan
Equity awards granted to Waters (NYSE: WAT) director Claire Fraser - Stock Titan
Director Richard Fearon receives equity awards in Waters (NYSE - Stock Titan
Waters (WAT) director awarded restricted shares and stock options - Stock Titan
Director Daniel J. Brennan receives equity grants at Waters (NYSE: WAT) - Stock Titan
Waters Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics and Performance Indicators - Markets Mojo
Waters Corporation $WAT Holdings Cut by Westpac Banking Corp - MarketBeat
TD Asset Management Inc Raises Stock Holdings in Waters Corporation $WAT - MarketBeat
Andra AP fonden Purchases 105,995 Shares of Waters Corporation $WAT - MarketBeat
Waters Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Waters Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Rep. Debbie Dingell Waters Corporation (NYSE:WAT) Shares - MarketBeat
Debbie Dingell makes transaction in Waters Corporation stocks from her brokerage account - Investing.com South Africa
Decoding Waters Corp (WAT): A Strategic SWOT Insight - GuruFocus
TD Cowen Health Care Conference to feature Waters CEO fireside chat - Stock Titan
Breaking Down Waters: 10 Analysts Share Their Views - Benzinga
WATERS CORP /DE/ SEC 10-K Report - TradingView
JPMorgan Chase & Co. Purchases 117,098 Shares of Waters Corporation $WAT - MarketBeat
Waters Corporation $WAT Shares Purchased by Kovitz Investment Group Partners LLC - MarketBeat
What Are Wall Street Analysts' Target Price for Waters Corporation Stock? - Barchart.com
Is Waters Corporation stock forming a triangle pattern2025 Trading Recap & Verified Entry Point Signals - mfd.ru
Alberta Investment Management Corp Takes $4.68 Million Position in Waters Corporation $WAT - MarketBeat
Waters introduces next-generation Microflow LC Columns with MaxPeak premier technology - Select Science
What Price Targets Have Wall Street Analysts Set for Waters Corporation Shares? - Bitget
Can Waters Corporation ride the EV waveOptions Play & Safe Capital Growth Plans - mfd.ru
1 S&P 500 Stock on Our Buy List and 2 We Ignore - Finviz
Waters Corp (WAT) Trading Down 3.86% on Feb 17 - GuruFocus
Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage - Finviz
Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage – Company AnnouncementFT.com - Financial Times
Waters Corporation (NYSE:WAT) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Rhumbline Advisers Buys 7,636 Shares of Waters Corporation $WAT - MarketBeat
Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y - Yahoo Finance
WAT Q4 Deep Dive: Acquisition Integrates BD Biosciences, Margin Pressures Offset Revenue Growth - Finviz
Agree To Purchase Waters At $270, Earn 5.2% Annualized Using Options - Nasdaq
Down 19.0% in 4 Weeks, Here's Why Waters (WAT) Looks Ripe for a Turnaround - Finviz
Waters (WAT) Q4 2025 Earnings Call Transcript - The Globe and Mail
Waters Corporation stock drops again as analysts reset targets after BD deal - Bez Kabli
Waters slips despite Q4 beat as outlook disappoints - MSN
Envestnet Asset Management Inc. Reduces Holdings in Waters Corporation $WAT - MarketBeat
Does Waters Corporation outperform in volatile marketsJuly 2025 Action & Accurate Buy Signal Alerts - baoquankhu1.vn
BD Merges Biosciences & Diagnostics Business With Waters - Yahoo Finance
Waters (WAT) Sees Price Target Downgrade by Wells Fargo | WAT St - GuruFocus
Waters Corporation (NYSE:WAT) Q4 2025 Earnings Call Transcript - Insider Monkey
Waters resumed with an In Line at Evercore ISI - Yahoo Finance
Finanzdaten der Waters Corp-Aktie (WAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
3.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):